Avenge Bio

Closed
Total Funding
$45.0M
Last Round
$45.0M Series AJan 2022
Rounds
1

About

Biotechnology company developing the LOCOcyte cell-therapy platform for immunotherapeutics dosing

Summary

It has raised $45.0M in total across 1 round, most recently a $45.0M Series A round in Jan 2022. Investors include Perceptive Advisors and CAM Capital.

Funding History

Series ASeries AJan 2022
$45.0M

Investors

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Avenge Bio on Indexed.vc
<a href="https://indexed.vc/companies/avenge-bio"><img src="https://indexed.vc/api/badge/company/avenge-bio" alt="Avenge Bio on Indexed.vc" width="260" height="76" /></a>